Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide.
Ontology highlight
ABSTRACT: Allogeneic blood or marrow transplantation (BMT) physicians seek to optimize all possible variables to improve outcomes. Selectable factors include conditioning, graft-versus-host disease (GVHD) prophylaxis, graft source, and donor. Many patients, especially those with eligible haploidentical (haplo) donors, will have multiple donor options. We seek to identify factors to optimize the choice of haplo donors when using posttransplantation cyclophosphamide (PTCy) GVHD prophylaxis. We evaluated the effect of modifiable donor characteristics (donor age and relationship) on outcomes following haplo BMT with a uniform nonmyeloablative conditioning and PTCy. From 2002 to 2017, 889 consecutive adult patients underwent nonmyeloablative haplo BMT with PTCy. Median follow-up among survivors was 2.5 y
SUBMITTER: DeZern AE
PROVIDER: S-EPMC7948266 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA